On‐Cell NMR Contributions to Membrane Receptor Binding

Total Page:16

File Type:pdf, Size:1020Kb

On‐Cell NMR Contributions to Membrane Receptor Binding Minireviews ChemPlusChem doi.org/10.1002/cplu.202100134 On-Cell NMR Contributions to Membrane Receptor Binding Characterization Theresa Höfurthner, Borja Mateos, and Robert Konrat*[a] ChemPlusChem 2021, 86, 938–945 938 © 2021 The Authors. ChemPlusChem published by Wiley-VCH GmbH Wiley VCH Mittwoch, 23.06.2021 2106 / 207714 [S. 938/945] 1 Minireviews ChemPlusChem doi.org/10.1002/cplu.202100134 NMR spectroscopy has matured into a powerful tool to by membrane receptors on the cell surface; therefore, charac- characterize interactions between biological molecules at terizing their interactions at atomic resolution by NMR, here- atomic resolution, most importantly even under near to native after referred as on-cell NMR, can provide valuable mechanistic (physiological) conditions. The field of in-cell NMR aims to study information. This review aims to summarize recent on-cell NMR proteins and nucleic acids inside living cells. However, cells tools that give information about the binding site and the interrogate their environment and are continuously modulated affinity of membrane receptors to their ligands together with by external stimuli. Cell signaling processes are often initialized potential applications to in vivo drug screening systems. 1. Introduction and their interactions in the near to native environment. It should not be confused with in vivo NMR, which refers to One of the most important features of living organisms is the interactions studies with living organisms, e.g. MRI. Addition- bidirectional communication capability to respond to their ally, with ex vivo NMR, important information about how the environment by reacting to stimuli from the extracellular space drug is affected under physiological conditions can be achieved, and respond by producing and secreting signaling molecules to as a drug might not be able to cross the cellular membrane, shape their surroundings. The essential response system might be pumped out of the cell, is metabolized or interacts comprises different membrane proteins embedded in the with other cellular components instead of the therapeutic plasma membranes of cells. The extracellular parts of mem- target.[6] Ex vivo NMR divides into investigations inside (in-cell brane receptors typically interact with a variety of molecules, NMR), at the membrane (on-cell NMR) and outside (ex-cell NMR) such as proteins, neurotransmitters, hormones, metabolites, of the living cell. In this review, we focus on the studies of ligands, and ions. Upon binding, the membrane receptor membrane receptors and their interactions by on-cell NMR. We activates different physiological processes by triggering signal- will address important considerations covering the expression ing cascades. Given their eminent biological functionalities, of membrane receptors with living mammalian cells, quantifica- they are attractive targets for many drug discovery projects. For tion of ligand binding, binding site mapping, and ultimately example, approximately 30% of all protein-coding genes in determination of binding poses. The aim of this mini-review is humans account for integral membrane proteins and 40% of all to guide the reader through the opportunities and difficulties of FDA-approved drugs target membrane proteins[1].[2] on-cell NMR and eventually simplify their entry to the new field. The structural and biochemical characterization of mem- brane proteins and their binding partners is still challenging, although various improvements in fields of sample preparation, 2. NMR in Biological Environments hardware and data processing have been accomplished in recent years.[3] Specifically, X-ray crystallography and cryo-EM 2.1. The cellular environment have been established as the methods of choice for large macromolecules, as they provide structural information about Typical structural biology projects are carried out in solutions macromolecules with high-resolution. containing few salts in a buffer that adjusts the pH. The cellular A unique method to probe molecular interactions and environment, however, is way more complex and contains a dynamics at atomic resolution, however, is nuclear magnetic plethora of other molecules such as metabolites, osmolytes, resonance (NMR), be it in the solid-state (SS-NMR) or liquid-state other proteins, nucleic acids, lipids and polymeric assemblies, (LS-NMR). Therefore, it has emerged as an indispensable tool in depending on the specifics of the cellular (sub)-system.[7] The drug discovery, as NMR can also detect changes of the cell’s interior, for example, is highly crowded, which influences conformation and dynamics upon ligand binding, providing not only the translational and rotational diffusion of the unique opportunities to target allosteric binding sites.[4,5] Most molecules in the cell but also the function of biomolecules.[9,10] importantly, the results of in vitro assays might be misleading or Several NMR studies provided insightful information on the inconclusive as the functionally relevant molecular interactions protein stability and function in crowded cellular occur either in the cell’s cytoplasm, at the external surface of conditions.[9,11–13] Additionally, subcellular compartments, like living cells or in the extracellular matrix (ECM). Ex vivo NMR cytoplasm, nucleus, mitochondria and lysosomes, confine the involves interaction studies with cells, tissues or organs and cell’s volume. Crowding and confinement have important therefore, provides unique possibilities to study biomolecules consequences for protein stability and reactivity, as proteins can interact with cellular milieu molecules, either by excluded [14] [a] T. Höfurthner, Dr. B. Mateos, Prof. R. Konrat volume of preferential interactions, and are altered by post- Department of Structural and Computational Biology translational modifications (PTMs).[15] For more details on in-cell Max Perutz Laboratories, University of Vienna Vienna Biocenter Campus 5, 1030 Vienna (Austria) NMR, we recommend other reviews that focus on this [7,16–18] E-mail: [email protected] topic. © 2021 The Authors. ChemPlusChem published by Wiley-VCH GmbH. This is When investigating membrane receptor interactions on the an open access article under the terms of the Creative Commons Attribution cell surface the details of the extracellular matrix has also to be Non-Commercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used considered, as it contains a significant number of polysacchar- for commercial purposes. ides (both in free form or as a part of protein glycosylation ChemPlusChem 2021, 86, 938–945 www.chempluschem.org 939 © 2021 The Authors. ChemPlusChem published by Wiley-VCH GmbH Wiley VCH Mittwoch, 23.06.2021 2106 / 207714 [S. 939/945] 1 Minireviews ChemPlusChem doi.org/10.1002/cplu.202100134 sites), important for several molecular recognition events, and method of choice, because it is a versatile platform to monitor secondary metabolites that are relevant for intercellular both the presence of reporter molecules of cellular fate and the communication.[19] Therefore, the ECM not only supports the expression of specific receptor types using monoclonal anti- mechanical stability of the cells but also is essential for outside- bodies. For example, it is possible to detect the presence of pre- in or inside-out signalling mechanism.[20] apoptotic cells with the annexin V assay as Annexin V binds to phosphatidylserines that migrates to the outer plasma mem- brane in apoptosis. In parallel, cell viability can be checked by 2.2. Receptor characterization propidium iodide or trypan blue staining. Thus, in a single assay, several reporters of viability, membrane receptor status When investigating membrane receptors in mammalian cells, it and cellular phenotype can be monitored. is important to know precisely the identity and quantity of the An essential prerequisite for the recording of NMR experi- protein. Both can be achieved by using mass spectrometry, ments with living cells is to maintain cell viability. To this end, commercial available microarrays and RNA sequencing.[21] Addi- the usage of bioreactors that enable the continuous exchange tionally, as a negative control, a cell line not expressing the of media in the NMR instruments have been proposed,[26–30] or membrane receptor should be established. To this end, CRISPR/ alternatively cells can be encapsulated within agar or alginate Cas9 technology has emerged as an excellent tool to manipu- hydrogels.[27] The problem, however, associated with these late the genome of cells.[22] With that methodology, tailored cell approaches is the fact that highly viscous gels are not suitable lines can be designed to address a specific question involving for LS-NMR as they prevent the free tumbling of the protein the membrane receptor of interest. This method has a great under study in solution. To circumvent this problem our potential in mimicking disease-related conditions by introduc- laboratory has recently developed an alternative experimental ing point mutations, gene deletion or insertions.[23] Furthermore, strategy involving methylcellulose hydrogels to prevent cells CRISPR/Cas can be used in designing and developing new from sedimentation. This approach ensures proper tumbling of drugs, especially for GPRCs, as they have a highly selective extracellular components, while retaining the cells attached to a pattern of expression and activity levels in healthy and disease (hydrogel) scaffold. Depending
Recommended publications
  • The Publications Files/27 Photopharmacology
    Minireviews ChemPhotoChem doi.org/10.1002/cptc.202100001 1 Very Important Paper 2 3 The Issue of Tissue: Approaches and Challenges to the 4 5 Light Control of Drug Activity 6 [a] [a] 7 Mayank Sharma and Simon H. Friedman* 8 9 10 Many of the major challenges associated with drug delivery can modulate drug release. Because of these and other advantages, 11 potentially be addressed by linking drug action to light a range of mechanisms for using light to manipulate drug 12 irradiation. These challenges include the spacing, timing and activity has been developed, including photocleavage control, 13 amount of a drug’s activity. Once a drug’s activity is linked to photoconformational control, photothermal control and photo- 14 light, this activity can be more easily manipulated, because light degradation control. These major themes of light control will be 15 itself is easy to manipulate. One of the main issues that light described in this minireview, and illustrated with examples. In 16 control can address is off-target toxicity. This has the potential addition, the issue of tissue light permittivity, arguably the 17 to be limited if drugs are activated only in target tissues using major challenge for the discipline, will be described and 18 light. For drugs that are needed at varying concentrations analyzed. 19 through the day, varying light has the potential to temporally 20 21 22 1. Introduction larger community of researchers using light to manipulate 23 biological phenomena. 24 Light is a powerful chemical reagent: Where light goes, when it 25 is applied, and the amount of light delivered are all factors that 26 are relatively easy to regulate.
    [Show full text]
  • Spotlights on Our Sister Journals: Chemistryopen 5
    On these pages, we feature aselection computer,click on any of the items to of the excellent work that has recently read the full article. Otherwise please been published in our sister journals. see the DOIs for easy online access If you are reading these pages on a through Wiley Online Library. Iodine Adducts A. Reinholdt, T. Vosch, J. Bendix* Modification of s-Donor Properties of TerminalCarbideLigands Investigated Through Carbide–Iodine AdductFormation To give and take:terminal ruthenium carbidecomplexes [(Cy P) X Ru C] (1;X= halide or pseudohalide), form charge-transfer 3 2 2 adducts with I2 exhibitinglarge variation in bond lengths and stretching frequencies. This showsthat the auxiliary ligand sphere on rutheniumenables control over the s-donor properties of car- bide ligands, elucidating their isolobal relationship with carbon monoxide. Angew.Chem. Int. Ed. DOI: 10.1002/anie.201606551 Density Functional Theory J. I. Schweizer, L. Meyer,A.Nadj, M. Diefenbach, M. C. Holthausen* Unraveling the Amine-Induced Disproportionation Reaction of Perchlorinated Silanes—A DFT Study Aneo twist:ADFT study on the amine-induceddisproportionation reactionofSi2Cl6 to neo-Si5Cl12 discloses astepwise rather than a concerted silylene insertion mechanism, which was generally ac- cepted for over half acentury. The resulting pictureappears gener- alizabletothe relatedchloride-induced chemistry recently explored (see graphic). Chem. Eur.J. DOI: 10.1002/chem.201602724 Aza-Diels–Alder Reactions Y. Kumatabara, S. Kaneko, S. Nakata,S.Shirakawa,* K. Maruoka Hydrogen-BondingCatalysis of TetraalkylammoniumSalts in an Aza-Diels–Alder Reaction Under observation:Apiperidine-derived tetraalkylammoniumsalt with anon-coordinating counteranion worked as an effective hydro- gen-bonding catalyst in an aza-Diels–Alder reactionofimines anda Danishefskydiene.
    [Show full text]
  • Annual Report: CY2018 Chempubsoc Europe
    1 Annual Report: CY2018 ChemPubSoc Europe Growth, change, awards, and sponsorship More scientists, more publications, more competition. As in the past, growth continued unabated worldwide in 2018 and is also reflected in the performance metrics of the ChemPubSoc Europe / Wiley-VCH publishing program, which now consists of 16 titles. The most recent product, ChemSystemsChem, was announced in Fall 2018. In 2018, the journals that are co-owned by ChemPubSoc Europe societies published nearly 9,000 articles (excluding contributions to the online publication ChemViews Magazine). Compared to the previous year, manuscript submissions grew by 12%, and the number of published articles rose by approximately 5%. A record number of full-text downloads, >8.9 million, was witnessed for the ChemPubSoc Europe journals, with increases in usage compared to the same time last year; notable among them ca. +20–30% for ChemCatChem, ChemElectroChem, ChemMedChem, and ChemPlusChem; and ca. +70% for ChemistrySelect and ChemPhotoChem. Approximately 3% of articles published in ChemPubSoc Europe's hybrid journals in 2018 were open access: ca. 10% at ChemBioChem and ca. 5% at ChemCatChem, Chemistry—A European Journal, ChemMedChem, and ChemPhysChem, respectively. ChemPubSoc Europe's gold open access journal, ChemistryOpen, experienced a ca. 47% growth in submissions compared to 2017. Generational change After the retirement of Peter Gölitz in November 2017, additional responsibility was taken on by Guido Herrmann (VP, Co-Managing Director Wiley-VCH, since April 1, 2017), Eva Wille (VP, Executive Director Wiley-VCH), Neville Compton (Editor-in-Chief of Angewandte Chemie and publisher for the GDCh journals), Haymo Ross (Editor-in-Chief of Chemistry—A European Journal and publisher of the ChemPubSoc Europe journals), Theresa Kueckmann (Editor-in-Chief of Chemistry—An Asian Journal and publisher for the Asian Chemical Editorial Society (ACES) journals), and Greta Heydenrych (development of new journals).
    [Show full text]
  • Wiley Article Publication Charges for Hybrid Open Updated: 17 March 2021
    Wiley Article Publication Charges for Hybrid Open Updated: 17 March 2021 Online Full Arti ISSN Journal Title USD $ 1467-6281 Abacus 2.500 1553-2712 Academic Emergency Medicine 3.000 1467-629X Accounting & Finance 3.000 1911-3838 Accounting Perspectives 2.500 1399-6576 Acta Anaesthesiologica Scandinavica 3.800 2053-2733 Acta Crystallographica Section A: Foundations and Advances 3.750 2052-5206 Acta Crystallographica Section B: Structural Science, Crystal Engineering and Mater 3.750 2053-2296 Acta Crystallographica Section C: Structural Chemistry 3.600 2059-7983 Acta Crystallographica Section D: Structural Biology 3.850 1755-6724 Acta Geologica Sinica (English Edition) 3.000 1600-0404 Acta Neurologica Scandinavica 4.000 1600-0412 Acta Obstetricia et Gynecologica Scandinavica 4.000 1755-3768 Acta Ophthalmologica 3.950 1651-2227 Acta Paediatrica: Nurturing the Child 3.300 1748-1716 Acta Physiologica 3.700 1600-0447 Acta Psychiatrica Scandinavica 3.600 1463-6395 Acta Zoologica 3.000 1360-0443 Addiction 3.700 1369-1600 Addiction Biology 3.700 2161-0029 Adultspan Journal 2.500 2701-0198 Advanced Biology 3.800 2578-0727 Advanced Control for Applications 2.500 2199-160X Advanced Electronic Materials 4.200 1614-6840 Advanced Energy Materials 5.000 1527-2648 Advanced Engineering Materials 4.100 1616-3028 Advanced Functional Materials 5.000 2192-2659 Advanced Healthcare Materials 4.200 1521-4095 Advanced Materials 5.000 2196-7350 Advanced Materials Interfaces 4.200 2365-709X Advanced Materials Technologies 4.200 2195-1071 Advanced Optical Materials
    [Show full text]
  • SCIENCE CITATION INDEX EXPANDED - JOURNAL LIST Total Journals: 8631
    SCIENCE CITATION INDEX EXPANDED - JOURNAL LIST Total journals: 8631 1. 4OR-A QUARTERLY JOURNAL OF OPERATIONS RESEARCH 2. AAPG BULLETIN 3. AAPS JOURNAL 4. AAPS PHARMSCITECH 5. AATCC REVIEW 6. ABDOMINAL IMAGING 7. ABHANDLUNGEN AUS DEM MATHEMATISCHEN SEMINAR DER UNIVERSITAT HAMBURG 8. ABSTRACT AND APPLIED ANALYSIS 9. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 10. ACADEMIC EMERGENCY MEDICINE 11. ACADEMIC MEDICINE 12. ACADEMIC PEDIATRICS 13. ACADEMIC RADIOLOGY 14. ACCOUNTABILITY IN RESEARCH-POLICIES AND QUALITY ASSURANCE 15. ACCOUNTS OF CHEMICAL RESEARCH 16. ACCREDITATION AND QUALITY ASSURANCE 17. ACI MATERIALS JOURNAL 18. ACI STRUCTURAL JOURNAL 19. ACM COMPUTING SURVEYS 20. ACM JOURNAL ON EMERGING TECHNOLOGIES IN COMPUTING SYSTEMS 21. ACM SIGCOMM COMPUTER COMMUNICATION REVIEW 22. ACM SIGPLAN NOTICES 23. ACM TRANSACTIONS ON ALGORITHMS 24. ACM TRANSACTIONS ON APPLIED PERCEPTION 25. ACM TRANSACTIONS ON ARCHITECTURE AND CODE OPTIMIZATION 26. ACM TRANSACTIONS ON AUTONOMOUS AND ADAPTIVE SYSTEMS 27. ACM TRANSACTIONS ON COMPUTATIONAL LOGIC 28. ACM TRANSACTIONS ON COMPUTER SYSTEMS 29. ACM TRANSACTIONS ON COMPUTER-HUMAN INTERACTION 30. ACM TRANSACTIONS ON DATABASE SYSTEMS 31. ACM TRANSACTIONS ON DESIGN AUTOMATION OF ELECTRONIC SYSTEMS 32. ACM TRANSACTIONS ON EMBEDDED COMPUTING SYSTEMS 33. ACM TRANSACTIONS ON GRAPHICS 34. ACM TRANSACTIONS ON INFORMATION AND SYSTEM SECURITY 35. ACM TRANSACTIONS ON INFORMATION SYSTEMS 36. ACM TRANSACTIONS ON INTELLIGENT SYSTEMS AND TECHNOLOGY 37. ACM TRANSACTIONS ON INTERNET TECHNOLOGY 38. ACM TRANSACTIONS ON KNOWLEDGE DISCOVERY FROM DATA 39. ACM TRANSACTIONS ON MATHEMATICAL SOFTWARE 40. ACM TRANSACTIONS ON MODELING AND COMPUTER SIMULATION 41. ACM TRANSACTIONS ON MULTIMEDIA COMPUTING COMMUNICATIONS AND APPLICATIONS 42. ACM TRANSACTIONS ON PROGRAMMING LANGUAGES AND SYSTEMS 43. ACM TRANSACTIONS ON RECONFIGURABLE TECHNOLOGY AND SYSTEMS 44.
    [Show full text]
  • 0 WILEY and MAYNOOTH UNIVERSITY WILEY READ AND
    WILEY and MAYNOOTH UNIVERSITY ________________________________________ WILEY READ AND PUBLISH AGREEMENT ________________________________________ 0 THIS AGREEMENT is made on the 15th day of March, 2021 BETWEEN: John Wiley & Sons, Inc., a New York corporation, 111 River Street, Hoboken, New Jersey 07030, and its affiliates Wiley Periodicals LLC, John Wiley & Sons, Ltd, John Wiley & Sons Australia, Ltd, Wiley-VCH GmbH, John Wiley & Sons A/S, collectively “Wiley” or “Publisher” AND National University of Ireland Maynooth, Maynooth University, whose principal address is at Maynooth, Co Kildare, Ireland (“Maynooth University”), acting on its own behalf and as non-exclusive agent on behalf of the other Members of the Consortium. RECITALS WHEREAS Maynooth University has been appointed by Members of the Consortium, as their non-exclusive agent, to enter into agreements on the Members’ behalf for accessing electronic educational and research resources; AND WHEREAS the Publisher provides Wiley Online Library which is an electronic collection of online journals, books, and research resources, covering life, health, social, and physical sciences, and the Publishing Privilege that gives authors the option to publish articles on an open access basis in select Wiley journals.; AND WHEREAS Maynooth University wishes to enter into this Agreement in order for Members of the Consortium to be authorised to access and use the Licensed Material; AND WHEREAS the Consortium and the Publisher share the goal to transition to an open access model and the transition to full open access will include continued access to the Publisher’s journal content, AND WHEREAS the parties are desirous to contract on the basis of the terms and conditions of this Agreement.
    [Show full text]
  • Novartis Chemistry Lectureship 20112012
    Angewandte. Angewandte News Chemie Novartis Chemistry Lectureship Barcelona, and was appointed professor there in 2011–2012 1986. Giralt is a member of the Editorial Advisory Awarded … Boards of ChemBioChem and Chemistry Open, and The Novartis Chemistry Lectureship is awarded to the International Advisory Boards of Chemistry— scientists in recognition of outstanding contribu- An Asian Journal and ChemMedChem. Giralts tions to organic and computational chemistry, research interests are in the fields of peptide including applications to biology. We congratulate synthesis, molecular recognition, and structure the recipients featured here, as well as Daniel determination, in particular using NMR spectros- Kahne (Harvard University) and Melanie S. San- copy. He has reported on 15N relaxation NMR ford (University of Michigan), who was recently studies of prolyl oligopeptidase in ChemBio- featured in this section.[1] Chem,[4a] and has discussed shuttle-mediated drug Yujiro Hayashi (Tokyo University of Science) delivery to the brain in a Review in Angewandte studied at Tokyo University and was awarded his Chemie.[4b] PhD in 1992 for work supervised by Koichi Tomislav Rovis (Colorado State University, Narasaka. He was a postdoctoral fellow with Fort Collins, USA) studied at the University of Y. Hayashi Elias J. Corey at Harvard University from 1994– Toronto, and earned his PhD in 1998 directed by 1996, and has been full professor at Tokyo Uni- Mark Lautens. From 1998–2000, he was a postdoc- versity of Science since 2006. Hayashi is on the toral fellow with David A. Evans at Harvard Academic Advisory Board of Advanced Synthesis University, and in 2000, he joined the faculty of & Catalysis and the International Advisory Board Colorado State University, where he currently of the European Journal of Organic Chemistry.
    [Show full text]
  • David Peralta (Editor-In-Chief, Chemmedchem, a Chemistry Europe Journal)
    Lecture Title: Publishing Ethics: Best practices in writing manuscripts Speaker: David Peralta (Editor-in-Chief, ChemMedChem, A Chemistry Europe Journal) Abstract: What constitutes plagiarism? To what extent is graphic optimization allowed? How do I properly cite other work? How should authorship be determined? What graphics/data from other papers can I use in my own manuscript? If you've had such questions, this talk is for you. We'll discuss ethical guidelines within the world of scientific publishing. We'll go through some of the most important rules students and professors should remember to make sure their research is written, published, and shared in an ethical manner. As such, we'll look at some examples of the most common unethical practices and also discuss what the repercussions are when such violations occur. We'll also explain how one can quickly and legally share one's published output. David Peralta studied chemistry and German culture and language at the Ateneo de Manila University, Philippines (BSc Chem 2006, MSc Chem 2009). There, he taught various courses in chemistry and science and society while finishing his MSc degree, focusing on organic, analytical, and biochemistry. In 2009, he moved to Germany for his PhD at the German Cancer Research Center (DKFZ), in the research group of Prof. Tobias Dick, working on redox biochemistry. In 2015, he earned his Dr. rer. nat. in biosciences/biochemistry from the DKFZ and the Ruprecht-Karls-Universität Heidelberg. Shortly before his doctoral defense, he joined Wiley-VCH in 2014 as an Assistant Editor for both ChemMedChem and ChemistryOpen, and later also ChemistrySelect.
    [Show full text]
  • YEARBOOK 2021 | 1 Editorial
    EFMC Yearbook 2021 Medicinal Chemistry and Chemical Biology in Europe EFMC-ISMC International Symposium on Medicinal Chemistry Virtual Event Aug. 29-Sept. 2, 2021 SESSIONS AND SESSION NEXT GENERATION DRUGS FOR HEART CONFIRMED PLENARY LECTURES COORDINATORS FAILURE Alleyn Plowright, Wren Therapeutics, UK Phil Baran, The Scripps Research Institute, US CHEMICAL BIOLOGY Karin Briner, Novartis, US RECENT ADVANCES IN ANTICANCER DRUG Jean-Paul Clozel, Idorsia, CH CARBOHYDRATE RECOGNITION AND DRUG DISCOVERY Stefan Knapp, Goethe University Frankfurt, DE DESIGN Roberto di Santo, Sapienza University of Rome, IT Alexander Titz, Helmholtz Institute for Pharmaceutical Sciences, DE TARGETING FIBROTIC DISEASES WITH SMALL MOLECULES EFMC AWARD LECTURES CHEMICAL APPROACHES TO STEM CELL Boehringer Ingelheim, DE DIFFERENTIATION (ICBS Session) THE NAUTA PHARMACOCHEMISTRY AWARD Colin Pouton, Monash University, AU TISSUE AND CELL SPECIFIC DRUG DELIVERY FOR MEDICINAL CHEMISTRY AND CHEMICAL (EUFEPS Session) BIOLOGY CHEMICAL PROBES FOR TARGET DISCOVERY Sébastien Papot, University of Poitiers, FR Ad P. Ijzerman, Leiden University, NL AND VALIDATION Gyorgy Keseru, Hungarian Academy of Sciences, HU TECHNOLOGIES IN MEDICINAL CHEMISTRY MOLECULAR IMAGING TOOLS FOR CHEMICAL Malin Lemurell, AstraZeneca, SE BIOLOGY APPLICATION OF ARTIFICIAL INTELLIGENCE Valle Palomo, CIB, ES IN DRUG DISCOVERY PROJECTS Christopher Swain, Cambridge MedChem AWARD FOR NEW TECHNOLOGIES IN DRUG PHOTOCHEMISTRY IN DRUG DISCOVERY: Consulting, UK DISCOVERY PHOTOPHARMACOLOGY, PHOTOTOXICITY Gisbert Schneider, ETH Zürich, CH AND SYNTHESIS (ACSMEDI Session) BIOCATALYSIS & LATE STAGE Timothy Henderson, MSD, US & Amjad Ali, MSD, US FUNCTIONALISATION Radka Snajdrova, Novartis, CH EFMC PARTNER PRIZES SMALL MOLECULES TARGETING RNA FUNCTION AND PROCESSING Maria Duca, University of Côte d'Azur, FR Jean-Paul Renaud, Urania Therapeutics, FR John E. Macor, Sanofi, US TARGET DECONVOLUTION STRATEGIES IN THE KLAUS GROHE AWARD DRUG DISCOVERY EXPANDING CHEMICAL SPACE THROUGH Stephan A.
    [Show full text]
  • On Behalf of the Regents of the University of California
    AMENllMENT TO WILEY ONLINE AGREEMENT Amendment as of January 1, 2019 to the Agreement (the " Agreement " John Wi ley & Sons, Jnc. ("Wiley US"), a New York corporation, and its affiliates, including without limitation, John Wiley & Son of England and Wales, VCH Verla GmbH & o. a , a company mcorporate un er l 1e aws o ("Wiley Germany") and John Wiley & Sons Australia, Ltd., (.. Wiley Australia"), collectively ''Wiley" as successor m interest to I ey Subscription Services, Inc. and The Regents of the University of California, a non-profit academic institution, with its rinci al offices at !he California Di ital Library, University of California Office of the President, SA (the "Customer"). In signing this Amendment, the parties agree that the following terms shall amend and supersede the tenns of said Agreement as follows: I. Paragraph A.2. shall be amended to replace "Licensee" with "Customer''. 2. Paragraph G. I. "Term and Termination" is amended and the tenn of the License is extended to end on December 31, 2019. 3. All applicable Product Appendices are amended to reflect the Licensed Electronic Products for the 201 9 calendar year and the respective pricing for 2019. 5. Paragraph J.12 in the EAL Amendment 2013-15 is removed for 2019 and Lawrence Livermore National Laboratory (LLNL) no longer receives access to the American Geophysical Union (AGU) titles via the California Digital Library license. For the avoidance of doubt, LLNL has perpetual rights to v. I through 2018 of the AGU titles, as stated in the Perpetual Access rights of the Agreement and there are no fees for LLNL's continued access lo the content.
    [Show full text]
  • Spotlights on Our Sister Journals: Chem. Asian J. 10/2016
    On these pages, we feature aselection computer,click on any of the items to of the excellent work that has recently read the full article. Otherwise please been published in our sister journals. see the DOIs for easy online access If you are reading these pages on a through Wiley Online Library. Anion Recognition M. Albrecht,* H. Yi,O.Kçksal, G. Raabe, F. Pan, A. Valkonen, K. Rissanen CF3:AnElectron-Withdrawing Substituent for Aromatic Anion Acceptors?“Side-On” versus“On-Top” Binding of Halides The place to be! Asubtle interplay of electronic effects at the aro- matic system and at aromatic Hatoms in connection with the polar- izability of the anion controlsthe position of anions in respecttoCF3 substituted aromatics. Chem. Eur.J. DOI: 10.1002/chem.201600249 Protein-Protein Interactions A. López, F. Herranz-Trillo, M. Kotev,M.Gairí, V. Guallar,P.Bernadó, O. Millet, T. Tarragó, E. Giralt* Active-Site-DirectedInhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics Aspoke on the wheels:Acombined approach based on NMR and SAXS experiments complemented by MD simulations has shown that active-site-directed inhibitors of prolyl oligopeptidase (POP) abolish the open/closed conformationalequilibrium. Probably,abol- ishing conformational dynamics by inhibitors causes significant alter- ations to molecular recognition events of POP. ChemBioChem DOI: 10.1002/cbic.201600102 Nanocrystals N. Pradhan* Red-Tuned Mn d–d Emission in Doped Semiconductor Nanocrystals Iprefer it in red:Emissiontuned from yellow to red can be ob- tained from Mn2+-doped semiconductor nanocrystals. By changing the environmentofthe Mn dopant in the crystal lattice,the Mn con- centration and the surfaceligands,the ligand-field splitting, and ChemPhysChem therefore also the Mn d–d emission, can be tuned.
    [Show full text]
  • Detailled CV
    Detailed CV Birth: December 6, 1940, St. Ulrich, Italy Marital status: married with Anne Marie Hellrigl, 1 child Address: Max-Planck-Institute of Biochemistry Bioorganic Chemistry Am Klopferspitz 18 D-82152 Martinsried Tel: +49-(0)89 / 8578-3905; [email protected]; www.biochem.mpg.de/en/rg/moroder/ Academic education 1959 - 1965 Chemistry at the University of Padova, Italy; graduate training in peptide chemistry in the laboratories of Prof. E. Scoffone 1965: Doctorate in Chemistry with summa cum laude: On the synthesis of the N-terminal eicosapeptide of ribonuclease A. Professional activities 1965 - 1967 Research assistant at the Institute of Organic Chemistry, University of Padova, Italy. 1968 - 1969 Research associate at the Protein Research Laboratory (Prof. K. Hofmann), University of Pittsburgh. 1975 - 1991 Staff scientist at the Max-Planck-Institute of Biochemistry, Department of Peptide Chemistry, Martinsried, Germany. 1971 Habilitation in Chemistry of Natural Products, Padova, Italy 1988 Habilitation at the Technical University of Munich, Faculty of Chemistry, Biology and Geology. 1990 Visiting Professor, Protein Research Institute, University of Osaka, Japan 1991- Head of the Laboratory of Bioorganic Chemistry, Institute of Biochemistry, Martinsried, Germany. 1992 Visiting Professor, University of Padova, Italy 1994- Apl. Professor, Technical University of Munich 1997 Visiting Professor, University of Neaples 1997-1998 Professor of Biochemistry and Biotechnology, TU München Awards 1995 Max-Bergmann-Medal 2004 Josef Rudinger Award 2008 Dimitrios Theodoropoulos Memorial Lecturer 2011 Doctor honoris causa, University of Cergy-Pontoise, Paris 2018 Akabori Memorial Award 2018 2020 Ernesto Scoffone Award Author and coauthor of 669 publications (491 in peer-reviewed journals and 178 as contributions to proceedings and books) Co-Editor of the 5-volume treatise Houben-Weyl, Methods of Organic Chemistry, Synthesis of Peptides and Peptidomimetics (Goodman, M.; Felix, A.; Moroder, L.; Toniolo, C., eds.) E 22a-e, Georg Thieme Verlag, Stuttgart, 2002/2003.
    [Show full text]